Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide in PCOS (REFUEL PCOS)
NCT05647356Unknown
- Sponsor
- Royal College of Surgeons of England
- Start
- Jan 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bicalutamide in polycystic ovary syndrome (PCOS), sponsored by Royal College of Surgeons of England. Primary endpoint: Impact of androgen receptor blockade on systemic and muscle-specific energy metabolism at 28 days. Status: unknown.
02
Drugs
bicalutamide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05647356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647356.